Wolverine Trading, LLC Inovio Pharmaceuticals, Inc. Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.35 - $0.53 $3,528 - $5,343	10,082 New	10,082 $5,000
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $29,357 - $49,341	17,685 New	17,685 $30,000
Q4 2021 Feb 14, 2022	SELL	$4.99 - $7.46 $139,225 - $208,141	-27,901 Reduced 62.29%	16,892 $88,000
Q1 2021 May 14, 2021	BUY	$8.81 - $16.96 $221,016 - $425,475	25,087 Added 127.31%	44,793 $395,000
Q4 2020 Feb 12, 2021	BUY	$8.5 - $12.85 $167,501 - $253,222	19,706 New	19,706 $177,000
Q3 2020 Nov 13, 2020	SELL	$9.57 - $27.05 $141,578 - $400,177	-14,794 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$7.14 - $31.69 $105,629 - $468,821	14,794 New	14,794 $469,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.